Reduced Leukoaraiosis, Noncardiac Embolic Stroke Etiology, and Shorter Thrombus Length Indicate Good Leptomeningeal Collateral Flow in Embolic Large-Vessel Occlusion.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
01 2022
Historique:
received: 20 05 2021
accepted: 20 09 2021
pubmed: 20 11 2021
medline: 11 3 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

Acute leptomeningeal collateral flow is vital for maintaining perfusion to penumbral tissue in acute ischemic stroke caused by large-vessel occlusion. In this study, we aimed to investigate the clinically available indicators of leptomeningeal collateral variability in embolic large-vessel occlusion. Among prospectively registered consecutive patients with acute embolic anterior circulation large-vessel occlusion treated with thrombectomy, we analyzed 108 patients admitted from January 2015 to December 2019 who underwent evaluation of leptomeningeal collateral status on pretreatment CTA. Clinical characteristics, extent of leukoaraiosis on MR imaging, embolic stroke subtype, time of imaging, occlusive thrombus characteristics, presenting stroke severity, and clinical outcome were collected. The clinical indicators of good collateral status (>50% collateral filling of the occluded territory) were analyzed using multivariate logistic regression analysis. Good collateral status was present in 67 patients (62%) and associated with independent functional outcomes at 3 months. Reduced leukoaraiosis (total Fazekas score, 0-2) was positively related to good collateral status (OR, 9.57; 95% CI, 2.49-47.75), while the cardioembolic stroke mechanism was inversely related to good collateral status (OR, 0.17; 95% CI, 0.02-0.87). In 82 patients with cardioembolic stroke, shorter thrombus length (OR, 0.91 per millimeter increase; 95% CI, 0.82-0.99) and reduced leukoaraiosis (OR, 5.79; 95% CI, 1.40-29.61) were independently related to good collateral status. Among patients with embolic large-vessel occlusion, reduced leukoaraiosis, noncardiac embolism mechanisms including embolisms of arterial or undetermined origin, and shorter thrombus length in cardioembolism are indicators of good collateral flow.

Sections du résumé

BACKGROUND AND PURPOSE
Acute leptomeningeal collateral flow is vital for maintaining perfusion to penumbral tissue in acute ischemic stroke caused by large-vessel occlusion. In this study, we aimed to investigate the clinically available indicators of leptomeningeal collateral variability in embolic large-vessel occlusion.
MATERIALS AND METHODS
Among prospectively registered consecutive patients with acute embolic anterior circulation large-vessel occlusion treated with thrombectomy, we analyzed 108 patients admitted from January 2015 to December 2019 who underwent evaluation of leptomeningeal collateral status on pretreatment CTA. Clinical characteristics, extent of leukoaraiosis on MR imaging, embolic stroke subtype, time of imaging, occlusive thrombus characteristics, presenting stroke severity, and clinical outcome were collected. The clinical indicators of good collateral status (>50% collateral filling of the occluded territory) were analyzed using multivariate logistic regression analysis.
RESULTS
Good collateral status was present in 67 patients (62%) and associated with independent functional outcomes at 3 months. Reduced leukoaraiosis (total Fazekas score, 0-2) was positively related to good collateral status (OR, 9.57; 95% CI, 2.49-47.75), while the cardioembolic stroke mechanism was inversely related to good collateral status (OR, 0.17; 95% CI, 0.02-0.87). In 82 patients with cardioembolic stroke, shorter thrombus length (OR, 0.91 per millimeter increase; 95% CI, 0.82-0.99) and reduced leukoaraiosis (OR, 5.79; 95% CI, 1.40-29.61) were independently related to good collateral status.
CONCLUSIONS
Among patients with embolic large-vessel occlusion, reduced leukoaraiosis, noncardiac embolism mechanisms including embolisms of arterial or undetermined origin, and shorter thrombus length in cardioembolism are indicators of good collateral flow.

Identifiants

pubmed: 34794948
pii: ajnr.A7360
doi: 10.3174/ajnr.A7360
pmc: PMC8757540
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-69

Informations de copyright

© 2022 by American Journal of Neuroradiology.

Références

J Cereb Blood Flow Metab. 2010 May;30(5):923-34
pubmed: 20125182
J Neurol. 2020 Nov;267(11):3362-3370
pubmed: 32588184
Ann Neurol. 2013 Aug;74(2):241-8
pubmed: 23536377
J Neurointerv Surg. 2019 Sep;11(9):866-873
pubmed: 30777890
Stroke. 2013 Aug;44(8):2194-9
pubmed: 23760216
Stroke. 2019 Jul;50(7):1751-1757
pubmed: 31233392
Medicine (Baltimore). 2017 Sep;96(39):e7682
pubmed: 28953609
J Cereb Blood Flow Metab. 2015 Aug;35(8):1249-59
pubmed: 25853908
AJNR Am J Neuroradiol. 2012 Aug;33(7):1331-6
pubmed: 22383238
Stroke. 2019 Dec;50(12):3360-3368
pubmed: 31658903
Mayo Clin Proc. 2019 Mar;94(3):380-382
pubmed: 30832786
J Neurol. 2019 Mar;266(3):582-588
pubmed: 30610425
Radiology. 2015 May;275(2):510-20
pubmed: 25633505
Neuroradiology. 2016 Oct;58(10):969-977
pubmed: 27438804
AJNR Am J Neuroradiol. 2009 Mar;30(3):525-31
pubmed: 19147716
J Neurointerv Surg. 2015 May;7(5):326-30
pubmed: 24721756
J Stroke Cerebrovasc Dis. 2014 Nov-Dec;23(10):2862-2868
pubmed: 25280817
Eur J Neurol. 2017 Jun;24(6):762-767
pubmed: 28432712
Cerebrovasc Dis. 2010;30(4):389-95
pubmed: 20693794
J Neurol Neurosurg Psychiatry. 2016 May;87(5):537-44
pubmed: 26063928
Stroke. 2011 May;42(5):1237-43
pubmed: 21393591
Stroke. 2014 Mar;45(3):759-64
pubmed: 24473178
J Neuroimaging. 2011 Jul;21(3):232-5
pubmed: 20977524
J Neurointerv Surg. 2020 Oct;12(10):942-945
pubmed: 31959635
Ann Neurol. 2007 Jun;61(6):533-43
pubmed: 17431875
J Neurointerv Surg. 2014 Apr 1;6(3):244-8
pubmed: 23703246
Can J Neurol Sci. 2015 Nov;42(6):381-8
pubmed: 26365832
Stroke. 2010 Oct;41(10):2316-22
pubmed: 20829514
Stroke. 2020 May;51(5):1493-1502
pubmed: 32279619
Stroke. 2018 Feb;49(2):391-396
pubmed: 29321337

Auteurs

T Hashimoto (T)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California tetsuyahashimoto629@hotmail.co.jp.

T Kunieda (T)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

T Honda (T)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

F Scalzo (F)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

L Ali (L)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

J D Hinman (JD)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

N M Rao (NM)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

M Nour (M)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

M Bahr-Hosseini (M)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

J L Saver (JL)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

R Raychev (R)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

D Liebeskind (D)

From the Department of Neurology and Comprehensive Stroke Center, University of California, Los Angeles, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH